- Participating Regulatory Authorities
- Participating Regulatory Authorities’ Official Websites
- ICMRA Fact Sheet
- Statements and Press Releases
- ICH reflection paper on integrating real-world evidence into regulatory decision-making (July 2023)
- ICMRA receives ‘Global Award for Outstanding Contribution to Health’ at DIA 2023 (July 2023)
- ICMRA report on AMR best practices (November 2022)
- ICMRA statement on Real-World Evidence (July 2022)
- ICMRA PQKMS Collaborative Pilot – Call for Industry Applications (June 2022)
- ICMRA Executive Committee response to situation in Ukraine
- Antimicrobial Resistance Statement (July 2019)
Antimicrobial Resistance Statement (French)
Antimicrobial Resistance Statement (Portuguese)
Antimicrobial Resistance Statement (Spanish) - ICMRA statement about confidence in biosimilar products (for healthcare professionals) (July 2019)
- ICMRA statement about confidence in biosimilar products (for patients and the public) (July 2019)
- Election of New Chair and Vice Chairs of ICMRA (July 2019)
- Zika Virus Disease Press Release (September 2016)
- Ebola Statement (August 2014)